EGFR and non-small cell lung carcinoma: Nair et al. [13] reported that the epidermal growth factor receptor (EGFR) mutations in NSCLC could be predicted by radiogenomic models based on radiomic features extracted from 18F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) images.